NASDAQ$AHCO

AdaptHealth Corp. · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Announced financial results for the first quarter ended March 31, 2021.

AdaptHealth Corp. reported strong Q1 2021 financial results, driven by the dedication of its employees and the successful integration of AeroCare. The company is increasing its financial guidance for fiscal year 2021.

  • AdaptHealth's Q1 2021 financial performance reflects the dedication of its 9,331 employees.
  • The results also reflect the hard work done by the AdaptHealth and AeroCare teams to complete the acquisition of AeroCare and combine operations.
  • The company experienced strong organic growth for the quarter.
  • The M&A pipeline remains strong.

Headline financials

Total Revenue

$482M

Previous: $191M+151.8%
EPS (adj)

$0.01

Previous: -$0.00+366.0%
Adjusted EBITDA

$125M

No prior period
Capital Expenditures

-$35.6M

Previous: -$7.53M-372.4%
Free Cash Flow

-$39.6M

Previous: -$7.69M-414.3%
Net Income

-$3.97M

Previous: -$158K-2407.6%
Operating Income

$15.4M

Previous: $9.31M+65.5%
Gross Profit

$85.4M

Previous: $24.9M+243.1%
Cash & Equivalents

$198M

Previous: $48.2M+310.5%
Total Assets

$4.52B

Previous: $662M+583.0%
Stock-Based Comp

$8.58M

Previous: $2.22M+286.1%

Revenue & EPS history

AdaptHealth · Revenue · Quarterly

$482M

Q1 2021+151.8%vs Q1 2020
Beat estimate in 4 of 9 quarters(44%)
ActualEstimate

Forward guidance

AdaptHealth is increasing its previously issued financial guidance for fiscal year 2021.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+0.6%

Avg return

Earnings day

+1.4%

Avg return

5 days after

+1.6%

Avg return

30 days after

52%

16 / 31 earnings

Positive

+34.6%

Q4 2023

Best reaction

-27.9%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-10.0%-13.4%-25.6%
Q4 2025-14.2%-11.1%+10.9%
Q3 2025+17.2%+4.5%+3.2%
Q1 2025+1.7%-1.4%+3.7%
Q4 2024+24.4%+33.1%+24.4%
Q3 2024+0.3%-0.6%-4.2%
Q2 2024-17.2%-14.1%+4.6%
Q1 2024-8.6%-8.8%+4.9%
Q4 2023+34.6%+37.9%+50.9%
Q3 2023-23.1%-18.6%-5.6%
Q2 2023+11.1%+4.4%-19.8%
Q1 2023-8.4%-12.2%-13.8%
Q4 2022-27.9%-27.9%-40.6%
Q3 2022-1.6%+8.4%+4.5%
Q2 2022-8.9%-8.2%-25.7%
Q1 2022+23.7%+42.2%+53.6%
Q4 2021+4.1%+2.3%+2.8%
Q3 2021-5.4%-7.2%-24.1%
Q2 2021+16.4%+13.4%+12.3%
Q1 2021-8.5%-14.9%-10.4%
Q4 2020+2.1%+12.4%+21.7%
Q3 2020+2.6%+0.6%+19.5%
Q2 2020+13.9%+18.0%+7.0%
Q1 2020+1.6%+5.8%+5.5%
Q4 2019+1.8%+1.4%-7.7%
Q3 2019-4.1%-4.9%-3.3%
Q2 2019+0.0%+0.0%-0.6%
Q1 2019+0.0%+0.0%+0.3%
Q4 2018+0.6%+0.7%+1.3%
Q3 2018+0.3%+0.1%+0.4%
Q2 2018+0.0%+0.3%+0.1%
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro